Wanda L Salzer

Summary

Affiliation: Walter Reed Army Medical Center
Country: USA

Publications

  1. ncbi Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Wanda L Salzer
    Keesler Medical Center, Keesler AFB, Biloxi, MS, USA
    J Pediatr Hematol Oncol 29:369-75. 2007
  2. ncbi Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas
    Brigitte C Widemann
    Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA
    J Clin Oncol 24:507-16. 2006

Detail Information

Publications2

  1. ncbi Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Wanda L Salzer
    Keesler Medical Center, Keesler AFB, Biloxi, MS, USA
    J Pediatr Hematol Oncol 29:369-75. 2007
    ..However, excessive toxicity occurred with intensified PEG-L-asparaginase and antimetabolite based therapy delivered on this schedule...
  2. ncbi Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas
    Brigitte C Widemann
    Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA
    J Clin Oncol 24:507-16. 2006
    ....